REVANCE THERAPEUTICS INC's ticker is RVNC and the CUSIP is 761330109. A total of 152 filers reported holding REVANCE THERAPEUTICS INC in Q4 2020. The put-call ratio across all filers is 2.06 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2022 | $1 | -100.0% | 100 | -90.4% | 0.00% | – |
| Q3 2022 | $28,000 | +250.0% | 1,045 | +63.5% | 0.00% | – |
| Q2 2022 | $8,000 | – | 639 | +1320.0% | 0.00% | – |
| Q1 2022 | $0 | – | 45 | 0.0% | 0.00% | – |
| Q4 2021 | $0 | -100.0% | 45 | -91.3% | 0.00% | – |
| Q3 2021 | $14,000 | -6.7% | 517 | 0.0% | 0.00% | – |
| Q2 2021 | $15,000 | +7.1% | 517 | 0.0% | 0.00% | – |
| Q1 2021 | $14,000 | +100.0% | 517 | +64.6% | 0.00% | – |
| Q3 2020 | $7,000 | +40.0% | 314 | +57.8% | 0.00% | – |
| Q2 2020 | $5,000 | 0.0% | 199 | -34.8% | 0.00% | – |
| Q1 2020 | $5,000 | – | 305 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| NovaQuest Capital Management, L.L.C. | 1,558,426 | $48,000,000 | 65.50% |
| Essex Woodlands Management, Inc. | 3,842,047 | $118,335,000 | 25.90% |
| Rhenman & Partners Asset Management AB | 203,181 | $6,258,000 | 0.77% |
| EAM Global Investors LLC | 44,898 | $1,383,000 | 0.72% |
| Fosun International Ltd | 319,313 | $9,835,000 | 0.62% |
| EAM Investors, LLC | 113,096 | $3,483,000 | 0.58% |
| ArrowMark Colorado Holdings LLC | 1,735,699 | $53,460,000 | 0.53% |
| Perceptive Advisors | 618,957 | $19,064,000 | 0.53% |
| ESSEX INVESTMENT MANAGEMENT CO LLC | 111,360 | $3,430,000 | 0.45% |
| Schonfeld Strategic Advisors LLC | 83,700 | $2,578,000 | 0.19% |